Rare diseases
Investigational molecules
Locations
Study of ivosidenib in adults with advanced or metastatic chondrosarcoma with IDH1 mutation who are untreated or have had one prior treatment
ItalyComparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
ItalyStudy on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors
ItalyStudy of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery
ItalyStudy of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
ItalyStudy on the Safety and Effectiveness of NMD670 for Adults with Myasthenia Gravis
ItalyStudy Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
ItalyStudy on Dapagliflozin for Patients with Decompensated Liver Cirrhosis
ItalyStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
ItalyStudy on Trabectedin for Adults and Young Adults with Advanced Mesenchymal Chondrosarcoma
ItalyStudy of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
